Cargando…
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188925/ https://www.ncbi.nlm.nih.gov/pubmed/21772330 http://dx.doi.org/10.1038/bjc.2011.240 |
| _version_ | 1782213419423760384 |
|---|---|
| author | Harrington, K J Billingham, L J Brunner, T B Burnet, N G Chan, C S Hoskin, P Mackay, R I Maughan, T S Macdougall, J McKenna, W G Nutting, C M Oliver, A Plummer, R Stratford, I J Illidge, T |
| author_facet | Harrington, K J Billingham, L J Brunner, T B Burnet, N G Chan, C S Hoskin, P Mackay, R I Maughan, T S Macdougall, J McKenna, W G Nutting, C M Oliver, A Plummer, R Stratford, I J Illidge, T |
| author_sort | Harrington, K J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3188925 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31889252012-08-23 Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers Harrington, K J Billingham, L J Brunner, T B Burnet, N G Chan, C S Hoskin, P Mackay, R I Maughan, T S Macdougall, J McKenna, W G Nutting, C M Oliver, A Plummer, R Stratford, I J Illidge, T Br J Cancer Guideline Nature Publishing Group 2011-08-23 2011-07-19 /pmc/articles/PMC3188925/ /pubmed/21772330 http://dx.doi.org/10.1038/bjc.2011.240 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Guideline Harrington, K J Billingham, L J Brunner, T B Burnet, N G Chan, C S Hoskin, P Mackay, R I Maughan, T S Macdougall, J McKenna, W G Nutting, C M Oliver, A Plummer, R Stratford, I J Illidge, T Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers |
| title | Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers |
| title_full | Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers |
| title_fullStr | Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers |
| title_full_unstemmed | Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers |
| title_short | Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers |
| title_sort | guidelines for preclinical and early phase clinical assessment of novel radiosensitisers |
| topic | Guideline |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188925/ https://www.ncbi.nlm.nih.gov/pubmed/21772330 http://dx.doi.org/10.1038/bjc.2011.240 |
| work_keys_str_mv | AT harringtonkj guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT billinghamlj guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT brunnertb guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT burnetng guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT chancs guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT hoskinp guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT mackayri guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT maughants guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT macdougallj guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT mckennawg guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT nuttingcm guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT olivera guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT plummerr guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT stratfordij guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT illidget guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers AT guidelinesforpreclinicalandearlyphaseclinicalassessmentofnovelradiosensitisers |